Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer's disease
Memory loss or dementia is a progressive disorder, and one of its common forms is Alzheimer's disease (AD), effecting mostly middle aged and older adults. In the present study, we developed Rivastigmine (RIV) nanoparticles using poly(lactic-co-glycolic acid) (RIV-loaded PLGA NPs) and polyvinyl...
Wedi'i Gadw mewn:
Prif Awduron: | Faisal Imam (Awdur), Sayantan Mukhopadhyay (Awdur), Preeti Kothiyal (Awdur), Samiyah Alshehri (Awdur), Khalid Saad Alharbi (Awdur), Muhammad Afzal (Awdur), Muzaffar Iqbal (Awdur), Mohammad Rashid Khan (Awdur), Md. Khalid Anwer (Awdur), Abdulrazaq Ahmed Hattab Alanazi (Awdur), Ali Ghanem Alqahtani (Awdur), Mohammed Abdullah Alhamamah (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Elsevier,
2024-05-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Polymeric Microneedles for Transdermal Delivery of Rivastigmine: Design and Application in Skin Mimetic Model
gan: Tânia M. T. Guimarães, et al.
Cyhoeddwyd: (2022) -
Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway
gan: Faisal Imam, et al.
Cyhoeddwyd: (2024) -
Acquired Localized Hypertrichosis Induced by Rivastigmine
gan: Adrian Imbernón-Moya, et al.
Cyhoeddwyd: (2016) -
QT interval prolongation and with donepezil, rivastigmine and galantamine
gan: Katie Malone, et al.
Cyhoeddwyd: (2020) -
Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
gan: Andreas Wentrup, et al.
Cyhoeddwyd: (2008)